Dr. Vicent leads the Oncogenes and Effector Targets (OnTarget) group in the Solid Tumors Program at CIMA-University of Navarra since 2014. The main two goals of his lab are: 1) to develop integrative gene expression analysis to identify central KRAS effectors across tumors, and 2) to uncover novel therapeutic strategies for the treatment of mutant KRAS tumors. Highlights of his group's work are the identification of a cross-tumors KRAS signature featuring common functional effectors, some of which have been adopted as a bona fide KRAS targets by the RAS community, and the discovery of new drug combinations with the potential to be translated to the clinic. He is a member of the Spanish Cancer Network CIBERONC, the Spanish Alliance on Pancreatic Cancer Research(ALIPANC), the European Precision Biliary Tract Network, and the Health Research Institute of Navarra (IdISNa) and the Cancer Center of the University of Navarra (CCUN). He is also an Associated Lecturer at the University of Navarra.